A prognostic indicator for the resection of liver metastasis of colorectal cancer

被引:19
作者
Amano, Ryosuke [1 ]
Yamada, Nobuya [1 ]
Nakata, Bunzo [1 ]
Kimura, Kenjiro [1 ]
Yashiro, Masakazu [1 ,2 ]
Ohira, Masaichi [1 ]
Hirakawa, Kosei [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka 5458585, Japan
关键词
Liver metastasis of colorectal cancer; Grade classification; JCCRC; MULTICENTER RANDOMIZED-TRIAL; LONG-TERM SURVIVAL; HEPATIC RESECTION; COLON-CANCER; PHASE-III; FLUOROURACIL; CHEMOTHERAPY; OXALIPLATIN; LEUCOVORIN; IRINOTECAN;
D O I
10.1007/s00595-013-0699-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
We investigated the predictive indicator for a good prognosis of surgical resection for liver metastasis of colorectal cancer. Between 1990 and 2009 at our institute, 117 patients underwent 132 hepatic resections for liver metastasis of colorectal cancer. The clinical, pathological, and outcome parameters affecting their prognoses were analyzed. The extent of the liver metastases was subdivided according to the Japanese Classification of Colorectal Carcinoma (JCCRC), and the patients were classified into different grades based on the JCCRC classification and the status of the nodal involvement of the primary tumor. The median survival time (MST) of the 117 patients was 58 months, and the actuarial survival rates at 1, 3, and 5 years were 92.3, 60.0, and 46.1 %, respectively. A multivariate analysis revealed that the JCCRC Grade classification was an independent prognostic indicator (Grade A vs. B vs. C: MST, 72 vs. 41 vs. 23 months; 5-year survival, 59.0 vs. 38.6 vs. 0 %: p < 0.0001). Our findings indicate that the JCCRC Grade classification for liver metastasis of colorectal cancer is a significant prognostic indicator and may be useful for making decisions regarding the treatment of liver metastasis.
引用
收藏
页码:1287 / 1292
页数:6
相关论文
共 34 条
[1]  
Adam R, 2001, ANN SURG ONCOL, V8, P347
[2]   Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? [J].
Adam, Rene ;
de Haas, Robbert J. ;
Wicherts, Dennis A. ;
Aloia, Thomas A. ;
Delvart, Valerie ;
Azoulay, Daniel ;
Bismuth, Henri ;
Castaing, Denis .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3672-3680
[3]   Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].
Andre, T ;
Boni, C ;
Mounedji-Boudiaf, L ;
Navarro, M ;
Tabernero, J ;
Hickish, T ;
Topham, C ;
Zaninelli, M ;
Clingan, P ;
Bridgewater, J ;
Tabah-Fisch, I ;
de Gramont, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351
[4]   Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin [J].
Aoki, Taku ;
Umekita, Nobutaka ;
Tanaka, Soichi ;
Noda, Kazumasa ;
Warabi, Masahiro ;
Kitamura, Masatsugu .
SURGERY, 2008, 143 (06) :706-714
[5]   Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer [J].
Arru, Marcella ;
Aldrighetti, Luca ;
Castoldi, Renato ;
Di Palo, Saverio ;
Orsenigo, Elena ;
Stella, Marco ;
Pulitano, Carlo ;
Gavazzi, Francesca ;
Ferla, Gianfranco ;
Di Carlo, Valerio ;
Staudacher, Carlo .
WORLD JOURNAL OF SURGERY, 2008, 32 (01) :93-103
[6]  
BENGMARK S, 1969, CANCER, V23, P198, DOI 10.1002/1097-0142(196901)23:1<198::AID-CNCR2820230126>3.0.CO
[7]  
2-J
[8]   A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery [J].
Beppu, Toru ;
Sakamoto, Yoshihiro ;
Hasegawa, Kiyoshi ;
Honda, Goro ;
Tanaka, Kuniya ;
Kotera, Yoshihito ;
Nitta, Hiroyuki ;
Yoshidome, Hiroyuki ;
Hatano, Etsuro ;
Ueno, Masaki ;
Takamura, Hiroyuki ;
Baba, Hideo ;
Kosuge, Tomoo ;
Kokudo, Norihiro ;
Takahashi, Keiichi ;
Endo, Itaru ;
Wakabayashi, Go ;
Miyazaki, Masaru ;
Uemoto, Shinji ;
Ohta, Tetsuo ;
Kikuchi, Ken ;
Yamaue, Hiroki ;
Yamamoto, Masakazu ;
Takada, Tadahiro .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2012, 19 (01) :72-84
[9]   Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial [J].
Douillard, JY ;
Cunningham, D ;
Roth, AD ;
Navarro, M ;
James, RD ;
Karasek, P ;
Jandik, P ;
Iveson, T ;
Carmichael, J ;
Alakl, M ;
Gruia, G ;
Awad, L ;
Rougier, P .
LANCET, 2000, 355 (9209) :1041-1047
[10]  
Fong Y, 1996, SEMIN SURG ONCOL, V12, P219, DOI 10.1002/(SICI)1098-2388(199607/08)12:4<219::AID-SSU3>3.3.CO